{"id":"https://openalex.org/W1992370441","doi":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","title":"THE ANTICHOLINESTERASE ACTIVITY OF MEFLOQUINE","display_name":"THE ANTICHOLINESTERASE ACTIVITY OF MEFLOQUINE","publication_year":1985,"publication_date":"1985-10-01","ids":{"openalex":"https://openalex.org/W1992370441","doi":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","mag":"1992370441","pmid":"https://pubmed.ncbi.nlm.nih.gov/3878759"},"language":"en","primary_location":{"id":"doi:10.1111/j.1440-1681.1985.tb00904.x","doi":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","pdf_url":null,"source":{"id":"https://openalex.org/S168193669","display_name":"Clinical and Experimental Pharmacology and Physiology","issn_l":"0305-1870","issn":["0305-1870","1440-1681"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Pharmacology and Physiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027178150","display_name":"Lee Yong Lim","orcid":"https://orcid.org/0000-0002-7307-0742","observed_orcids":["https://orcid.org/0000-0002-7307-0742"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"L. Y. Lim","raw_affiliation_strings":["Department of Pharmacy, National University of Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, National University of Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I165932596"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029259484","display_name":"Mei\u2010Lin Go","orcid":"https://orcid.org/0000-0003-4757-3343","observed_orcids":["https://orcid.org/0000-0003-4757-3343"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]}],"countries":["SG"],"is_corresponding":true,"raw_author_name":"M. L. Go","raw_affiliation_strings":["Department of Pharmacy, National University of Singapore, Republic of Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, National University of Singapore, Republic of Singapore","institution_ids":["https://openalex.org/I165932596"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029259484"],"corresponding_institution_ids":["https://openalex.org/I165932596"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.09482433,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"12","issue":"5","first_page":"527","last_page":"531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mefloquine","display_name":"mefloquine","score":1.0},{"id":"https://openalex.org/keywords/anticholinesterase-activity","display_name":"anticholinesterase activity","score":0.9210000038146973},{"id":"https://openalex.org/keywords/acetylcholinesterase","display_name":"acetylcholinesterase","score":0.9210000038146973},{"id":"https://openalex.org/keywords/butyrylcholinesterase","display_name":"butyrylcholinesterase","score":1.0},{"id":"https://openalex.org/keywords/non-competitive-inhibition","display_name":"non-competitive inhibition","score":0.8180000185966492},{"id":"https://openalex.org/keywords/chloroquine","display_name":"chloroquine","score":0.8840000033378601},{"id":"https://openalex.org/keywords/amodiaquine","display_name":"amodiaquine","score":1.0},{"id":"https://openalex.org/keywords/antimalarial-drugs","display_name":"antimalarial drugs","score":0.8550000190734863},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.6340000033378601},{"id":"https://openalex.org/keywords/central-nervous-system-adverse-effects","display_name":"central nervous system adverse effects","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C2777199930","wikidata":"https://www.wikidata.org/wiki/Q736270","display_name":"Mefloquine","level":4,"score":0.9067146182060242},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47586125135421753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40563613176345825},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.08210131525993347},{"id":"https://openalex.org/C2777425658","wikidata":"https://www.wikidata.org/wiki/Q422438","display_name":"Chloroquine","level":3,"score":0.0530487596988678},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.05187395215034485}],"mesh":[{"descriptor_ui":"D000655","descriptor_name":"Amodiaquine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002091","descriptor_name":"Butyrylcholinesterase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002738","descriptor_name":"Chloroquine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002802","descriptor_name":"Cholinesterases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006736","descriptor_name":"Horses","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1440-1681.1985.tb00904.x","doi":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1681.1985.tb00904.x","pdf_url":null,"source":{"id":"https://openalex.org/S168193669","display_name":"Clinical and Experimental Pharmacology and Physiology","issn_l":"0305-1870","issn":["0305-1870","1440-1681"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Pharmacology and Physiology","raw_type":"journal-article"},{"id":"pmid:3878759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3878759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental pharmacology & physiology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W22236944","https://openalex.org/W1519535680","https://openalex.org/W1602738763","https://openalex.org/W2002889793","https://openalex.org/W2011866372","https://openalex.org/W2028227654","https://openalex.org/W2048491257","https://openalex.org/W2048684492","https://openalex.org/W2058869559","https://openalex.org/W2070956865","https://openalex.org/W2071643844","https://openalex.org/W2072664867","https://openalex.org/W2316282107","https://openalex.org/W2411944660","https://openalex.org/W2413155122","https://openalex.org/W2469723326"],"related_works":["https://openalex.org/W2411944660","https://openalex.org/W2071691849","https://openalex.org/W2097126978","https://openalex.org/W1492698815","https://openalex.org/W2110950220","https://openalex.org/W2334093465","https://openalex.org/W2039211695","https://openalex.org/W2027012889","https://openalex.org/W2996714126","https://openalex.org/W4404378949"],"abstract_inverted_index":{"The":[0,26,59],"characteristics":[1],"of":[2,5,34,63,72,83],"the":[3,16,47,70,84],"inhibition":[4],"electric":[6],"eel":[7],"acetylcholinesterase":[8],"(AChE)":[9],"and":[10,22,37,74],"horse":[11],"serum":[12],"butyrylcholinesterase":[13],"(BChE)":[14],"by":[15],"antimalarial":[17],"agents":[18],"mefloquine,":[19],"chloroquine,":[20],"amodiaquine":[21,49],"amopyroquine":[23,52],"were":[24,28,45],"determined.":[25],"antimalarials":[27],"found":[29],"to":[30],"be":[31],"non-competitive":[32],"inhibitors":[33],"both":[35,40],"AChE":[36],"BChE.":[38],"In":[39],"enzyme":[41],"systems,":[42],"inhibitory":[43,61],"potencies":[44],"in":[46,67],"order":[48],"greater":[50,53,56],"than":[51,54,57],"chloroquine":[55],"mefloquine.":[58],"low":[60],"potency":[62],"mefloquine":[64],"may":[65],"account":[66],"part":[68],"for":[69],"appearance":[71],"gastrointestinal":[73],"central":[75],"nervous":[76],"system":[77],"disturbances":[78],"only":[79],"at":[80],"high":[81],"doses":[82],"drug.":[85]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}